116 related articles for article (PubMed ID: 6788893)
1. Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells.
Marino PA; Whisnant CC; Adams DO
J Exp Med; 1981 Jul; 154(1):77-87. PubMed ID: 6788893
[TBL] [Abstract][Full Text] [Related]
2. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
Johnson WJ; Whisnant CC; Adams DO
J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis.
Johnson WJ; Bolognesi DP; Adams DO
Cell Immunol; 1984 Jan; 83(1):170-80. PubMed ID: 6420078
[TBL] [Abstract][Full Text] [Related]
4. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
Adams DO; Marino PA; Meltzer MS
J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of tumor cell capture by activated macrophages: evidence for involvement of lymphocyte function-associated (LFA)-1 antigen.
Strassmann G; Springer TA; Somers SD; Adams DO
J Immunol; 1986 Jun; 136(11):4328-33. PubMed ID: 2422281
[TBL] [Abstract][Full Text] [Related]
6. Interaction of Bacillus Calmette--Guérin-activated macrophages and neoplastic cells in vitro II. The relationship of selective binding to cytolysis.
Marino PA; Adams DO
Cell Immunol; 1980 Aug; 54(1):26-35. PubMed ID: 6773673
[No Abstract] [Full Text] [Related]
7. The role of transmethylation reactions in regulating the binding of BCG-activated murine macrophages to neoplastic target cells.
Adams DO; Pike MC; Snyderman R
J Immunol; 1981 Jul; 127(1):225-30. PubMed ID: 7240742
[TBL] [Abstract][Full Text] [Related]
8. The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types.
Somers SD; Mastin JP; Adams DO
J Immunol; 1983 Oct; 131(4):2086-93. PubMed ID: 6413586
[TBL] [Abstract][Full Text] [Related]
9. The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG.
Koren HS; Meltzer MS; Adams DO
J Immunol; 1981 Mar; 126(3):1013-5. PubMed ID: 7007498
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
Adams DO; Johnson WJ; Marino PA
Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages.
Somers SD; Whisnant CC; Adams DO
J Immunol; 1986 Feb; 136(4):1490-6. PubMed ID: 3080524
[TBL] [Abstract][Full Text] [Related]
13. Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages.
Nathan CF; Terry WD
J Exp Med; 1975 Oct; 142(4):887-902. PubMed ID: 170358
[TBL] [Abstract][Full Text] [Related]
14. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors.
Adams DO
J Immunol; 1980 Jan; 124(1):286-92. PubMed ID: 6985641
[TBL] [Abstract][Full Text] [Related]
15. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
Marino PA; Adams DO
J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
[TBL] [Abstract][Full Text] [Related]
16. High strength binding of P815 mastocytoma cells is not necessary for their lysis by macrophages which have been primed and triggered in vitro.
Lu CY; Lombardi MJ; Shea CM; Dustin LB
J Immunol; 1988 Aug; 141(4):1083-90. PubMed ID: 3135320
[TBL] [Abstract][Full Text] [Related]
17. Effects of assay medium composition on macrophage-mediated tumor cell binding and lysis.
Hasday JD; Crawford EK
J Immunol Methods; 1988 Nov; 114(1-2):243-52. PubMed ID: 3141516
[TBL] [Abstract][Full Text] [Related]
18. Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms.
Klostergaard J; Leroux ME; Ezell SM; Kull FC
Cancer Res; 1987 Apr; 47(8):2014-9. PubMed ID: 3828989
[TBL] [Abstract][Full Text] [Related]
19. Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.
Freedman VH; Calvelli TA; Silagi S; Silverstein SC
J Exp Med; 1980 Sep; 152(3):657-73. PubMed ID: 6997425
[TBL] [Abstract][Full Text] [Related]
20. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
Klostergaard J; Leroux ME; Hung MC
J Immunol; 1991 Oct; 147(8):2802-8. PubMed ID: 1918993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
